RofsteinC, CummingsKM, NicolaouAL, LuceyJ, FitzpatrickJ.Nosocomial infection rates at an oncology centre. Infection Control and Hospital Epidemiology1988; 19: 13–19.
2.
MorantR, SennH.The management of infections in Palliative Care. In: DoyleD, HanksG, MacDonaldN(eds). Oxford Textbook of Palliative Medicine. New York: Oxford University Press, 1993; pp. 378–384.
3.
ChanockS.Evolving risk factors for infectious complications of cancer therapy. Hematology/Oncology Clinics of North America1993; 7 (4):771–793.
4.
StuckAE, MinderCE, FreyFJ. Risk of infectious complications in patients taking glucocorti-costeroids. Rev Infect Dis1989; 11 (6):954–963.
5.
SchimpffSC. Gram-negative bacteremia. Supportive Care in Cancer1993; 1: 5–18.
6.
GleckmanRA. Pneumonia: Update on diagnosis and treatment. Geriatrics1991; 46 (2):49–56.
7.
GrantonJ, HylandH.Pneumonia in the elderly, an update. Geriatrics1992; Nov-Dec; 51–62.
8.
LödeH.Initial therapy in pneumonia: clinical, radiographic, and laboratory data important for the choice. Am J Med1986; 80(5C): 70–74.
9.
NormanDC. Pneumonia in the elderly: empiric antimicrobial therapy. Geriatrics1991; 46 (12):26–32.
10.
Hirata-DulasCAI, SteinDJ, GuayDRP, GruningerRP, PetersonPK. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing-home-acquired lower respiratory tract infections. J Am Ger Soc1991; 39 (10):979–985.
11.
FabreD, BressolleF, GomeniR.Arich C, Lemesle F, Beziau H, Galter M. Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: prevention of the bronchial mucosa. Antimicrobial Agents and Chemotherapy1991; 35 (12):2521–2525.
12.
PaladinoJA, SperryHE, BackesJM, GelberJA, SerrianneDJ, CumboJJ, SchentagJJ. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med1991; 91: 462–470.
13.
RappRP, BilleterM, HattonJ, YoungAB, TibbsPA, DempseyRJ. Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection. Clinical Pharmacy1991; 10: 49–54.
14.
MandellLA, BergeronM, LowD, Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Can Med Assoc J1994; 150 (5):669–76.
15.
SaundersH.Antibiotics in office practice: making the right choice. J Can CME1992; May: 55–62.
16.
BrownNK, ThompsonDJ. Nontreatment of fever in extended care facilities. New Engl J Med1979; 300 (22):1246–1250.
17.
Council on Ethical and Judicial Affairs, American Medical Association. Decisions near the end of life. JAMA1992; 267 (16):2229–2233.
